Tamoxifen
FDA Approved
Contents
Description
Tamoxifen is a selective estrogen receptor modulator primarily used in breast cancer treatment. It has been used off-label in cases of virginal breast hypertrophy to reduce breast tissue growth by blocking estrogen receptors. The medication can help manage severe cases of juvenile macromastia when conservative measures fail.
Indications & Therapeutic Use
Breast cancer, virginal breast hypertrophy, gynecomastia, mastalgia
Linked Diseases:
virginal breast hypertrophy
C536821
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Tamoxifen — GNH India
122 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Adifen
EU
Adifen 10mg
EU
Ebefen
EU
Kessar
EU
Nolvadex
EU
Nolvadex D
EU
Nolvadex-D
EU
Nomafen
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tamoxifen
| Generic Name | Tamoxifen |
| Brands | 1 brand available |
| Active Ingredient | Tamoxifen citrate |
| Drug Class | Breast cancer |
| Manufacturer | AstraZeneca |
| Dosage Forms | Oral tablets 10mg, 20mg |
| Medical Code | L02BA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes